As of Jul 28
| +0.06 / +3.00%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +118.45% increase from the last price of 2.06.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.